Effect of cyclosporine during initiation of transplant arteriosclerosis. An ultrastructural study in the aorta-transplanted rabbit

Atherosclerosis

Volumn 133, Issue 2, 1997, Pages 171-181

  Andersen, Henrik Ørbæk ^a   Qvortrup, Klaus ^b,c   Rostgaard, Jørgen ^c   Nordestgaard, Børge G ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Aorta allografted rabbit; Cyclosporine; Scanning transmission microscopy; Transmission electron microscopy; Transplant arteriosclerosis

Indexed keywords

CYCLOSPORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA GRAFT; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; LYMPHOCYTIC INFILTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; AORTA, ABDOMINAL; AORTA, THORACIC; ARTERIOSCLEROSIS; BODY WEIGHT; CHOLESTEROL; CYCLOSPORINE; ENDOTHELIUM; GRAFT REJECTION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICROSCOPY; MICROSCOPY, ELECTRON; MICROSCOPY, ELECTRON, SCANNING; RABBITS; TRANSPLANTATION, HOMOLOGOUS; VEHICLES;

EID: 0030868984     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00123-8     Document Type: Article

References (63)

1. Hosenpud J.D., Shipley G.D., Wagner C.R. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant. 11:1992;9-23.
2. Billingham M.E. Cardiac transplant atherosclerosis. Transplant Proc. 19:1987;19-25.
3. Russell ME, Fujita M, Masek MA, Rowan RA, Billingham ME. Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation 1993;56:1599-1601. Corrected and republished article: originally printed in Transplantation 1993;56(3):762-764.
4. Russell ME, Fujita M, Masek MA, Rowan RA, Billingham ME. Cardiac graft vascular disease. Nonselective involvement of large and small vessels. Transplantation 1993;56:1599-1601. Corrected and republished article: originally printed in Transplantation 1993;56(3):762-764.
5. Miller L.W. Long-term complications of cardiac transplantation. Prog Cardiovasc Dis. 33:1991;229-282.
6. Mennander A., Tiisala S., Paavonen T., Halttunen J., Hayry P. Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis. Transplant Int. 4:1991;173-179.
7. Paul L.C., Davidoff A., Benediktsson H. Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor. Transplantation. 57:1994;1767-1772.
8. Stoltenberg R.L., Geraghty J., Steele D.M., Kennedy E., Hullett D.A., Sollinger H.W. Inhibition of intimal hyperplasia in rat aortic allografts with cyclosporine. Transplantation. 60:1995;993-998.
9. Koskinen P.K., Lemstrom K.B., Hayry P.J. How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts. Am J Pathol. 146:1995;972-980.
10. DeCampli W.M., Johnson D.E., Gao S.Z., Schroeder J.S., Billingham M., Stinson E.B., Shumway N.E. Transplant coronary vascular disease: histomorphometric properties and clinical correlations. Curr Surg. 45:1988;477-480.
11. Hess M.L., Hastillo A., Thompson J.A., Sansonetti D.J., Szentpetery S., Barnhart G., Lower R.R. Lipid mediators in organ transplantation: does cyclosporine accelerate coronary atherosclerosis? Transplant Proc. 19:1987;71-73.
12. Gao SZ, Schroeder JS, Alderman EL, Hunt SA, Valantine HA, Wiederhold V, Stinson EB. Prevalence of accelerated coronary artery disease in heart transplant survivors. Comparison of cyclosporine and azathioprine regimens, Circulation 1989;80:III100-III105.
13. Rickenbacher P.R., Kemna M.S., Pinto F.J., Hunt S.A., Alderman E.L., Schroeder J.S., Stinson E.B., Popp R.L., Chen I., Reaven G., Valentine H.A. Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors. Transplantation. 61:1996;46-53.
14. Miller L., Kobashigawa J., Valantine H., Ventura H., Hauptman P., O'Donnel J., Wiedermann J., Yeung A. The impact of cyclosporine dose and level on the development and progression of allograft coronary disease. J Heart Lung Transplant. 14:1995;S227-S234.
15. Addonizio LJ, Hsu DT, Douglas JF, Kichuk MR, Michler RE, Quaegebeur JM, Smith CR, Rose EA. Decreasing incidence of coronary disease in pediatric cardiac transplant recipients using increased immunosuppression. Circulation 1993;88:II224-II229.
16. Andersen H.O., Madsen G., Nordestgaard B.G., Hansen B.F., Kjeldsen K., Stender S. Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability. Arterioscler Thromb. 14:1994;944-950.
17. Territo M., Berliner J.A., Fogelman A.M. Effect of monocyte migration on low density lipoprotein transport across aortic endothelial cell monolayers. J Clin Invest. 74:1984;2279-2284.
18. Flecknell P.A., Mitshell M. Midazolam and fentanyl-fluanisone: assessment of anaesthetic effects in laboratory rodents and rabbits. Lab Anim. 18:1984;143-146.
19. Rostgaard J., Qvortrup K., Poulsen S.S. Improvements in the technique of vascular perfusion-fixation employing a fluocarbon-containing perfusate and a peristaltic pump controlled by pressure feedback. J Microsc. 172:1993;137-151.
20. Andersen H.O., Holm P., Nordestgaard B.G., Hansen B.F., Kjeldsen K., Elinder L.S., Stender S. Effect of the antioxidant probucol on transplant arteriosclerosis in aorta-allografted rabbits. J Mol Cell Cardiol. 27:1995;1561-1571.
21. Rostgaard J., Christensen P.A. A multipurpose specimen carrier for handling small biological objects through critical point drying. J Microsc. 105:1975;107-113.
22. Rostgaard J, Tranum-Jensen J. A procedure for minimizing cellular shrinkage in electron microscope preparation: a quantitative study in the frog gall bladder. J Microsc 1980;119:213-232.
23. Malik L.E., Wilson R.B. Evaluation of a modified technique for SEM examination of vertebrate specimens without evaporated metal layers. IITRI/Scan Electron Microsc. 2:1975;259-264.
24. +-ATPase to the inside of the basolateral cell membranes of epithelial cells of proximal and distal tubules in rabbit kidney. Cell Tissue Res. 212:1980;17-28.
25. Fujita T., Ushiki T. Scanning electron microscopic observations of the immunodefensive systems with special reference to the surface morphology of the non-lymphoid cells. Arch Histol Cytol. 55:1992;105-113.
26. Male D, Roitt I. Introduction to the immune system. In: Roitt I, Brostoff J, Male D, editors. Immunology. London: Mosby, 1993:1-12.
27. Nichols B.A., Bainton D.F., Farquhar M.G. Differentiation of monocytes. Origin, nature and fate of their azuraphil granules. J Cell Biol. 20:1971;498-515.
28. Grossi C.E., Webb S.R., Zicca A., Lydyard P.M., Moretta L., Mingari M.M., Cooper M.D. Morphological and histochemical analyses of two human T-cell subpopulations bearing receptors for IgM or IgG. J Exp Med. 147:1996;1405-1417.
29. Grossi C.E., Zicca A., Cadoni A., Mingari M.C., Moretta A., Moretta L. Ultrastructural characteristics of human T cell clones with various cytolytic activities. Eur J Immunol. 13:1983;670-677.
30. Ferrarini M., Cadoni A., Franzi A.T., Ghigliotti C., Leprini A., Zicca A., Grossi C.E. Ultrastructure and cytochemistry of human peripheral blood lymphocytes. Similarities between the cells of the third population and TG lymphocytes. Eur J Immunol. 10:1980;562-570.
31. Campbell G.R., Campbell J.H., Manderson J.A., Horrigan S., Rennick R.E. Arterial smooth muscle. A multifunctional mesenchymal cell. Arch Pathol Lab Med. 112:1988;977-986.
32. Tanaka H., Sukhova G.K., Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb. 14:1994;734-745.
33. Andersen H.O., Holm P., Stender S., Hansen B.F., Kjeldsen K., Nordestgaard B.G. Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts. Transplantation. 60:1995;631-638.
34. Hruban R.H., Beschorner W.E., Baumgartner W.A., Augustine S.M., Ren H., Reitz B.A., Hutchins G.M. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol. 137:1990;871-882.
35. Salomon R.N., Hughes C.C., Schoen F.J., Payne D.D., Pober J.S., Libby P. Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol. 138:1991;791-798.
36. Paavonen T., Mennander A., Lautenschlager I., Mattila S., Hayry P. Endothelialitis and accelerated arteriosclerosis in human heart transplant coronaries. J Heart Lung Transplant. 12:1993;117-122.
37. Springer T.A. Adhesion receptors of the immune system. Nature. 346:1990;425-434.
38. Adams D.H., Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet. 343:1994;831-836.
39. Tanaka H., Sukhova G.K., Swanson S.J., Cybulsky M.I., Schoen F.J., Libby P. Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol. 144:1994;938-951.
40. Forbes R.D.C., Guttmann R.D., Gomersall M., Hibberd J. A controlled serial ultrastructural tracer study of first-set cardiac allograft rejection in the rat. Evidence that the microvascular endothelium is the primary target of graft destruction. Am J Pathol. 111:1983;184-196.
41. Johnson D.E., Gao S.Z., Schroeder J.S., DeCampli W.M., Billingham M.E. The spectrum of coronary artery pathologic findings in human cardiac allografts. J Heart Transplant. 8:1989;349-359.
42. Mennander A., Tiisala S., Halttunen J., Yilmaz S., Paavonen T., Hayry P. Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arterioscler Thromb. 11:1991;671-680.
43. Lemström K.B., Räisänen-Sokolowski A.K., Häyry P.J., Koskinen P.K. Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat. Arterioscler Thromb Vasc Biol. 16:1996;553-564.
44. Nakagawa T., Sukhova G.K., Rabkin E., Winters G.L., Schoen F.J., Libby P. Acute rejection accelerates graft coronary disease in transplanted rabbit hearts. Circulation. 92:1995;987-993.
45. Yilmaz S., Hayry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation. 56:1993;1153-1156.
46. Uretsky B.F., Murali S., Reddy P.S., Rabin B., Lee A., Griffith B.P., Hardesty R.L., Trento A., Bahnson H.T. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 76:1987;827-834.
47. Narrod J., Kormos R., Armitage J., Hardesty R., Ladowski J., Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant. 8:1989;418-420.
48. Zerbe T., Uretsky B., Kormos R., Armitage J., Wolyn T., Griffith B., Hardesty R., Duquesnoy R. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant. 11:1992;S104-S110.
49. Carrier M., Pelletier G., Leclerc Y., Castonguay Y., Cartier R., Dyrda I., Gosselin G., Pelletier L.C. Accelerated coronary atherosclerosis after cardiac transplantation: major threat to long-term survival. Can J Surg. 34:1991;133-136.
50. Kahan B.D. Cyclosporine. N Engl J Med. 321:1989;1725-1738.
51. Kuwahara M., Jacobsson J., Kagan E., Ramwell P.W., Foegh M.L. Coronary artery ultrastructural changes in cardiac transplant atherosclerosis in the rabbit. Transplantation. 52:1991;759-765.
52. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med. 314:1986;488-500.
53. Ferns G., Reidy M., Ross R. Vascular effects of cyclosporine A in vivo and in vitro. Am J Pathol. 137:1990;403-413.
54. Garbasch C., Tranum-Jensen J., van Deurs B. Scanning and transmission electron microscopy of the normal rabbit aortic endothelium after controlled perfusion fixation. Acta Anat. 112:1982;79-91.
55. Leszczynski D., Zhao Y., Yeagley T.J., Foegh M.L. Direct and endothelial cell-mediated effect of cyclosporin A on the proliferation of rat smooth muscle cells in vitro. Am J Pathol. 142:1993;149-155.
56. Zoja C., Furci L., Chiraldi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 55:1986;455-462.
57. Jonasson L., Holm J., Hansson G.K. Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury. Proc Natl Acad Sci USA. 85:1988;2303-2306.
58. Chan B.B.K., Kern J.A., Flanagan T.L., Kron I.L., Tribble C.G. Effects of in vivo cyclosporine administration on endothelium-dependent responses in isolated vascular rings. Circulation. 86:1992;295-299.
59. Johnson D.E., Alderman E.L., Schroeder J.S., Gao S.Z., Hunt S., DeCampli W.M., Stinson E., Billingham M. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol. 17:1991;449-457.
60. St. Goar F.G., Pinto F.J., Alderman E.L., Valantine H.A., Schroeder J.S., Gao S.Z., Stinson E.B., Popp R.L. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of 'angiographically silent' intimal thickening. Circulation. 85:1992;979-987.
61. Handa N., Hatanaka M., Baumgartner W.A., Reitz B.A., Sandford G., Esa A.H., Herskowitz A. Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts. Transplantation. 56:1993;535-540.
62. Chomette G., Auriol M., Cabrol C. Chronic rejection in human heart transplantation. J Heart Transplant. 7:1988;292-297.
63. Kuo P., Monaco A.P. Chronic rejection and suboptimal immunosuppression. Transplant Proc. 25:1993;2082-2084.